Videos

Here are the top 5 biosimilar articles for the week of December 16, 2024.

Elie Bahou, PharmD, senior vice president and system chief pharmacy officer at Providence, discussed barriers to biosimilar adoption and highlighted strategies such as physician education, streamlined implementation, payer collaboration, and patient engagement to improve access, reduce costs, and enhance adherence to biologic therapies.

Here are the top 5 biosimilar articles for the week of December 9, 2024.

Steve Pickette, PharmD, BCPS, emphasizes that AI can streamline prescribing and formulary management for biosimilars and generics, enhance provider engagement, and improve pharmacovigilance by tracking adoption rates and identifying potential issues.

Here are the top 5 biosimilar articles for the week of December 2, 2024.

Here are the top 5 biosimilar articles for the week of November 25, 2024.

Here are the top 5 biosimilar articles for the week of November 18, 2024.

This webinar celebrating Global Biosimilars Week was hosted by The Center for Biosimilars® in partnership with the International Generics and Biosimilars Association.

Here are the top 5 biosimilar articles for the week of November 11, 2024.

Sophia Humphreys, PharmD, MHA, BCBBS, director of system formulary management at Sutter Health, discusses how integrated delivery networks (IDNs) can help drive biosimilar adoption.

Here are the top 5 biosimilar articles for the week of November 4, 2024.

Here are the top 5 biosimilar articles for the week of October 28, 2024.

Here are the top 5 biosimilar articles for the week of October 21, 2024.

Sophia Humphreys, PharmD, from Sutter Health explains that expanding biosimilars into new therapeutic areas faces hesitance due to maintenance therapies, emphasizing the importance of education.

Here are the top 5 biosimilar articles for the week of October 14, 2024.

Ivo Abraham, PhD, RN, director of the Center for Health Outcomes and PharmacoEconomic Research at the University of Arizona Cancer Center, discusses the potential of biosimilars and challenges in the US, emphasizing partnerships for market growth.

Here are the top 5 biosimilar articles for the week of October 7, 2024.

Here are the top 5 biosimilar articles for the week of September 30, 2024.

Ivo Abraham, PhD, RN, University of Arizona Cancer Center, explains how biosimilars are becoming more accessible but face challenges like price erosion and potential shortages.

Here are the top 5 biosimilar articles for the week of September 23, 2024.

Ivo Abraham, PhD, RN, University of Arizona Cancer Center, analyzes the need for innovative risk-sharing models to promote biosimilar development and utilization.

Here are the top 5 biosimilar articles for the week of September 16, 2024.

Here are the top 5 biosimilar articles for the week of September 9, 2024.

Ivo Abraham, PhD, RN, University of Arizona Cancer Center, urges stakeholders to provide patient advocacy groups with comprehensive information about specific drugs and drug classes to increase patient understanding of biosimilars and promote informed decision-making.

Here are the top 5 biosimilar articles for the week of September 2, 2024.

Here are the top 5 biosimilar articles for the week of August 26, 2024.

Ivo Abraham, PhD, RN, University of Arizona Cancer Center, suggests implementing targeted educational strategies to overcome physician hesitancy towards biosimilar adoption.

Here are the top 5 biosimilar articles for the week of August 19, 2024.

Here are the top 5 biosimilar articles for the week of August 12, 2024.

Ivo Abraham, PhD, RN, University of Arizona Cancer Center, focused on the cost savings generated by biosimilars and how crucial reinvesting those savings into broader patient access to care is. This approach has the potential to improve health care equity and expand treatment options for patients.